1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA: Cancer J. Clin.,2021
2. Biomarkers for immunotherapy response in head and neck cancer;Gavrielatou;Cancer Treat. Rev.,2020
3. administration Ufad. FDA approves pembrolizumab for first-line treatment of head and neck squamous cell carcinoma 2019 [Available from: 〈https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-first-line-treatment-head-and-neck-squamous-cell-carcinoma〉.
4. Biomarkers and 3D models predicting response to immune checkpoint blockade in head and neck cancer (Review);Affolter;Int. J. Oncol.,2022
5. Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy;Wang;Br. J. Cancer,2023